The incidence, impact, and risk factors for moderate to severe persistent pain after breast cancer surgery: a prospective cohort study
Pain Medicine · 01.09.2023 · 24 (9) · 1023-1034
DOI: 10.1093/pm/pnad065 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pain Medicine, online erschienen am 15.05.2023. Verfasst von Daniel L C Chiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Perioperative & Pain Medicine, Waitemata District Health Board, Auckland, New Zealand. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANZCA Research, ANZCA Research Foundation, Australian and New Zealand College of Anaesthetists.
Abstract (Originalsprache)
Background
Few Australasian studies have evaluated persistent pain after breast cancer surgery.
Objective
To evaluate the incidence, impact, and risk factors of moderate to severe persistent pain after breast cancer surgery in a New Zealand cohort.
Design
Prospective cohort study Methods Consented patients were reviewed at 3 timepoints (preoperative, 2 weeks and 6 months postoperative). Pain incidence and interference, psychological distress and upper limb disability were assessed perioperatively. Clinical, demographic, psychological, cancer treatment-related variables, quantitative sensory testing, and patient genotype (COMT, OPRM1, GCH1, ESR1, and KCNJ6) were assessed as risk factors using multiple logistic regression.
Results
Of the 173 patients recruited, 140 completed the 6-month follow-up. Overall, 15.0% (n = 21, 95% CI: 9.5%—22.0%) of patients reported moderate to severe persistent pain after breast cancer surgery with 42.9% (n = 9, 95% CI: 21.9%—66.0%) reporting likely neuropathic pain. Pain interference, upper limb dysfunction and psychological distress were significantly higher in patients with moderate to severe pain (P < .004). Moderate to severe preoperative pain (OR= 3.60, 95% CI: 1.13–11.44, P = .03), COMT rs6269 GA genotype (OR = 5.03, 95% CI: 1.49—17.04, P = .009) and psychological distress at postoperative day 14 (OR= 1.08, 95% CI: 1.02—1.16, P = .02) were identified as risk factors. Total intravenous anesthesia (OR= 0.31, 95% CI: 0.10 – 0.99, P = .048) was identified as protective.
Conclusion
The incidence of moderate to severe persistent pain after breast cancer surgery is high with associated pain interference, physical disability, and psychological distress. Important modifiable risk factors were identified to reduce this important condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology, Perioperative & Pain Medicine, Waitemata District Health Board, Auckland, New Zealand.
- Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand.
- Department of Anaesthesiology, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand.
- Health and Rehabilitation Research Institute, School of Clinical Sciences, Auckland University of Technology, Auckland, New Zealand.
- Department of Molecular Medicine and Pathology, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand.
- Discipline of Pharmacology, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Daniel L C Chiang, Andrew A Somogyi
Förderung
- ANZCA Research
- ANZCA Research Foundation
- Australian and New Zealand College of Anaesthetists
Zitieren
APA
Chiang, D. L. C., Rice, D. A., Helsby, N. A., Somogyi, A. A., & Kluger, M. T. (2023). The incidence, impact, and risk factors for moderate to severe persistent pain after breast cancer surgery: a prospective cohort study. Pain Medicine, 24(9), 1023-1034. https://doi.org/10.1093/pm/pnad065
Vancouver
Chiang DLC, Rice DA, Helsby NA, Somogyi AA, Kluger MT. The incidence, impact, and risk factors for moderate to severe persistent pain after breast cancer surgery: a prospective cohort study. Pain Medicine. 2023;24(9):1023-1034. doi:10.1093/pm/pnad065
BibTeX
@article{Chiang2023,
author = {Chiang, Daniel L C and Rice, David A and Helsby, Nuala A and Somogyi, Andrew A and Kluger, Michal T},
title = {The incidence, impact, and risk factors for moderate to severe persistent pain after breast cancer surgery: a prospective cohort study},
journal = {Pain Medicine},
year = {2023},
volume = {24},
number = {9},
pages = {1023--1034},
doi = {10.1093/pm/pnad065}
}
EUVIMED